Inverclyde Biologicals, Source BioScience plc deal

Diagnostics and genetic analysis company Source BioScience acquired Inverclyde Biologicals for £1.6 million ($2.5 million) in cash. Inverclyde, which manufactures diagnostic kits and blood group serol...